Zhejiang Taimei Medical Technology Co (FRA:A2V) Marketable Securities: €68.72 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:A2V Zhejiang Taimei Medical Technology Co Ltd FRA:A2V
11 GF Score
Price €0.62
! 4 Warning Signs
View Full Analysis

What is Zhejiang Taimei Medical Technology Co Marketable Securities?

Zhejiang Taimei Medical Technology Co FRA:A2V +2.50% 11 Marketable Securities is €68.72 Mil as of Dec. 2025. GuruFocus rates FRA:A2V with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Zhejiang Taimei Medical Technology Co's Marketable Securities for the quarter that ended in Dec. 2025 was €68.72 Mil.

Zhejiang Taimei Medical Technology Co's annual Marketable Securities increased from Dec. 2023 (€70.64 Mil) to Dec. 2024 (€115.44 Mil) but then declined from Dec. 2024 (€115.44 Mil) to Dec. 2025 (€68.72 Mil).

Zhejiang Taimei Medical Technology Co  (FRA:A2V) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Zhejiang Taimei Medical Technology Co Marketable Securities Related Terms

Zhejiang Taimei Medical Technology Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Zhejiang Taimei Medical Technology Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Taimei Medical Technology Co Marketable Securities Chart

Zhejiang Taimei Medical Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
100.08 100.35 70.64 115.44 68.72

Zhejiang Taimei Medical Technology Co Semi-Annual Data
Dec21 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial 70.64 0.00 115.44 108.21 68.72
FRA:A2V
11GF Score
Zhejiang Taimei Medical Technology Co Ltd FRA:A2V
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Taimei Medical Technology Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €68.72 Mil mean?
Zhejiang Taimei Medical Technology Co (FRA:A2V) has a Marketable Securities of €68.72 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Zhejiang Taimei Medical Technology Co and its competitors.
Is Zhejiang Taimei Medical Technology Co's Marketable Securities too high?
Zhejiang Taimei Medical Technology Co's current Marketable Securities is €68.72 Mil. Overall, Zhejiang Taimei Medical Technology Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Taimei Medical Technology Co's Marketable Securities compare to VEEV and BTSG?
Zhejiang Taimei Medical Technology Co's Marketable Securities of €68.72 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. Zhejiang Taimei Medical Technology Co's current Marketable Securities is €68.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Taimei Medical Technology Co stock overvalued right now?
Zhejiang Taimei Medical Technology Co (FRA:A2V) has a current Marketable Securities of €68.72 Mil. The current Marketable Securities is €68.72 Mil. Zhejiang Taimei Medical Technology Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Zhejiang Taimei Medical Technology Co (FRA:A2V), the current Marketable Securities is €68.72 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zhejiang Taimei Medical Technology Co Business Description

Other Exchanges 02576:Hong Kong
Address 36 Changsheng South Road, 3rd Floor, Building 9, Smart Industry Innovation Park, Zhejiang Province, Jiaxing, CHN
Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China. It designs and delivers industry-specific software and digital services that facilitate research and development (R&D) and the commercialization of pharmaceuticals and medical devices. The software it offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. It has a geographical presence in Mainland China, the United States, Singapore, Korea, and Others.
11GF Score

Get the complete analysis for FRA:A2V

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.62
Price